Scientists at Washington State University have developed a method to detect biomarkers for Alzheimer's disease that is 10 times more sensitive than current blood testing technology. The researchers created an artificial enzyme using a single-atom architecture that was able to work as efficiently as natural enzymes. Their artificial enzyme, called a nanozyme, is made of single iron atoms embedded in nitrogen-doped carbon nanotubes.
An official website of the United States government.